EYWA PHARMA PVT LTD HIRING CANDIDATES FOR REGULATORY AFFAIRS (RA) DEPARTMENT @ CHENNAI

ABOUT COMPANY :

Aging Population, healthcare costs, supply interruptions and accessibility to affordable, high quality medicines are some of the challenges faced by patients and healthcare systems around the world. We at Eywa Pharma intend to make a difference with our endeavor to provide continuous access to affordable, high quality medicines for patients, globally. With this vision, Eywa Pharma Pte. Ltd. was born in April 2015.

The parent company, Eywa Pharma Pte. Ltd., is incorporated in Singapore with operations/ subsidiaries in India (Eywa Pharma Private Ltd – R&D), Europe (Zista Pharma Limited,UK – Commercial operations) and in the USA (Eywa Pharma Inc.- Commercial operations and Manufacturing).

In about 4 years, the company has built a strong, diverse generic drug portfolio including limited competition, high volume and difficult to manufacture products that cover a variety of therapeutic areas and dosage forms, including tablets, capsules, oral suspensions and solutions through a combination of in-house development and strategic in-licensing.

We develop our products at our development facility located in Chennai, India as well as through our strategic global network of partners. The company has established a state-of-the-art oral solid dosage manufacturing facility in Cranbury, New Jersey, USA.

We have commercially launched products under the Eywa Label in the U.S. and under the Zista name in UK along with entering into strategic private label opportunities (e.g., unit dose). As a result, our products are available to patients and pharmacies through all channels (e.g., wholesalers, secondary distributors, buying groups etc.).

We are actively extending our product portfolio to China and other growing markets, through partnerships to ensure access to patients and healthcare systems globally.

The company has rapidly progressed from incorporation to first US commercial launch with:

• Investment from Eight Roads Ventures India (the proprietary investment arm of FIL, Fidelity International Limited), US-based F-Prime Capital Partners and Envestor Ventures Limited together with its affiliates (part of the Shriram Group, Chennai, India),
• an Active Product Portfolio of 70+ products
• a Global workforce of 100+ people
• 38 ANDAs (Abbreviated New Drug Application) and MAs (Marketing Authorisations) filed and over 23 approvals received as of December 2019, including in-licensed products.

Eywa Pharma Pvt Ltd, Chennai (R&D) is looking for a Manager-Regulatory Affairs with 7 to 10 years of experience. 

The candidate should have exposure to both US and Europe markets. 

Area of Responsibility

1. New Submissions, compilation & submission of Annual Reports

2. Approval

3. Lifecycle management for drug Formulations

4.Regulatory compliance.

Salary as per the industry standard and based on his current CTC/experience.

Interested candidates can mail the cvs to mail ID vasanthipriya.r@eywapharma.com.

Thanks

Eywa Pharma HR

Vasanthi Priya R

For more updates follow 

www.globalpharmanews.co.in

Thank you for visiting my website, Visit again for 

latest pharma updates